US 12,220,381 B2
Drug security systems and methods
Michael A. Lafauci, Center Moriches, NY (US); Jeffrey R. Wahl, Beachwood, OH (US); Andrew M. Brown, Hackensack, NJ (US); and Jonathan Pinsky, Bedford, NY (US)
Assigned to MIDAS Healthcare Solutions, Inc., Center Moriches, NY (US)
Filed by MIDAS Healthcare Solutions, Inc., Center Moriches, NY (US)
Filed on Oct. 25, 2021, as Appl. No. 17/509,691.
Application 17/509,691 is a continuation of application No. PCT/US2020/029588, filed on Apr. 23, 2020.
Claims priority of provisional application 62/873,617, filed on Jul. 12, 2019.
Claims priority of provisional application 62/839,361, filed on Apr. 26, 2019.
Prior Publication US 2022/0142862 A1, May 12, 2022
Int. Cl. A61J 1/14 (2023.01); A61J 1/16 (2023.01); A61J 1/20 (2006.01)
CPC A61J 1/1437 (2013.01) [A61J 1/1406 (2013.01); A61J 1/16 (2013.01); A61J 1/201 (2015.05); A61J 1/2096 (2013.01); A61J 2205/10 (2013.01)] 18 Claims
OG exemplary drawing
 
1. An injectable medication security device, comprising:
a recess provided on a first portion of the device, wherein the recess is configured to receive and couple to a neck portion of a vial containing the injectable medication;
an opening provided on a second portion of the device, wherein the opening permits access to a penetrable cover located near the neck portion of the vial;
at least one aperture located at the opening and configured to control access to the opening; and
a depressible switch operatively coupled to the at least one aperture, wherein the depressible switch is configured to (1) cause the at least one aperture to open and provide access to the opening when the depressible switch is depressed, thereby permitting the medication to be drawn from the vial, and (2) cause the at least one aperture to lock and close the opening when the depressible switch is released, thereby preventing further access to any residual medication within the vial.